Related Experiment Videos
Hemodynamic effects of calcium channel blockers in essential hypertension
Insights
Calcium channel blockers lower blood pressure by reducing vascular resistance. However, their effectiveness in enhancing vasodilation is reduced after treatment with other antihypertensives.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Hypertension Research
Background:
- Essential hypertension is characterized by elevated blood pressure.
- Calcium channel blockers (CCBs) are a key class of antihypertensive drugs.
- CCBs primarily reduce blood pressure by decreasing systemic vascular resistance.
Purpose of the Study:
- To investigate the effect of CCBs on vascular tone in essential hypertension.
- To examine the influence of prior antihypertensive treatment on CCB responsiveness.
Main Methods:
- Review of existing literature on CCB mechanisms and effects.
- Analysis of vasodilatory responsiveness in resistance vessels.
- Comparison of CCB effects in different phases of hypertension and after other drug treatments.
Main Results:
- CCBs reduce systemic vascular resistance and lower blood pressure.
- Vasodilatory responsiveness to CCBs is enhanced in established essential hypertension.
- Treatment with diuretics (chlorthalidone) or beta-blockers (atenolol, acebutolol) reduces responsiveness to CCBs.
Conclusions:
- CCBs effectively lower blood pressure through arteriolar vasodilation.
- Established hypertension shows enhanced vasodilatory response to CCBs.
- Concurrent or prior treatment with other antihypertensives can diminish the vasodilatory effects of CCBs.
Abstract:
Calcium channel blockers decrease blood pressure in essential hypertension due to a marked reduction of systemic vascular resistance (arteriolar tone). They also dilate conducting arteries but have no venodilatory effect in antihypertensive doses. With the dihydropyridines (e.g. nifedipine) and diltiazem there is a transient increase in heart rate and cardiac output but this is not observed with verapamil. The vasodilatory responsiveness in the resistance vessels to calcium channel blockers is selectively enhanced in patients with established essential hypertension but not in the early borderline phase of hypertension. During treatment with chlorthalidone, atenolol, acebutolol or nitrendipine for four to six weeks the reduction of blood pressure is accompanied by a selective decrease in the vasodilatory responsiveness to calcium channel blockers.